What minimum storage temperature is required for long-term cell viability in cryopreservation?

Cells stored below –130°C in liquid-nitrogen vapor phase maintain viability for decades, as metabolic activity effectively ceases below the glass-transition point [4]. Most GMP biobanks target –150°C to –196°C for therapeutic-grade samples. Read More

How do buyers evaluate controlled-rate freezers versus passive freezing containers?

Controlled-rate freezers offer programmable cooling profiles suited to sensitive cell types, while passive containers use isopropanol-based cooling at roughly –1°C per minute [13]. Buyers should match the device to cell-type sensitivity and throughput volume needs. Read More

What role does DMSO-free media play in improving patient safety during cell therapy infusions?

DMSO-free formulations eliminate infusion-related side effects such as nausea and cardiac arrhythmia observed in up to 10% of patients receiving DMSO-laden thawed products [14]. Adoption is accelerating among CGT manufacturers prioritizing patient tolerability. Read More

How are decentralized clinical trials changing cryopreservation logistics requirements?

Decentralized trials ship biological materials between multiple sites, demanding validated portable cryogenic cell storage units with real-time temperature monitoring [12]. This trend is expanding addressable demand beyond centralized lab settings. Read More

What accreditation should buyers look for when selecting a biorepository partner?

ISBER and CAP accreditation are the two most recognized standards for biological sample preservation facilities [16]. Both require documented quality-management systems, chain-of-custody tracking, and validated storage protocols. Read More

How does vitrification differ from slow-freezing for oocyte preservation outcomes?

Vitrification uses ultra-rapid cooling to form a glass-like solid, avoiding ice-crystal damage that degrades oocyte integrity during slow-freeze protocols [4]. Post-thaw survival rates exceed 95% with vitrification versus 60–75% with slow-freezing. Read More

What emerging insurance and employer-benefit trends are driving demand for elective fertility cryopreservation?

Over 40% of Fortune 500 firms now offer fertility preservation benefits covering oocyte or embryo freezing, up from 19% in 2019 [7]. This employer-funded demand is a significant growth channel for IVF-linked cell freezing storage solutions. Read More

Cell Cryopreservation Market

ID: MRFR/LS/19935-HCR

128 Pages

Nidhi Mandole

Last Updated: June 22, 2026

Cell Cryopreservation Market Research Report Information By Type (Cell Freezing Media, Equipment, Consumables, and Others), By Application (Stem Cells, oocyte cells, Sperm Cells, and Others), By End User (Pharmaceutical and Biotechnology Companies, Research Institute, Biobanks, IVF Clinics, and Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2035

Cell Cryopreservation Market

Market Size

Forecast Period2026-2035

CAGR (2026-2035)19.8%

2025 Market SizeUSD 14.93 Billion

2035 Market SizeUSD 90.92 Billion

Key Players

Thermo Fisher Scientific

Merck KGaA

BioLife Solutions

Chart Industries

Exact Sciences

Worthington Industries

Trends

Cell and Gene Therapy Manufacturing Scale-Up
Government Biobank Expansion Programs
Elective Fertility Preservation Surge

Opportunities

Emerging-Market Biobank Build-Outs
Cryopreservation-as-a-Service Business Models
AI-Powered Bioprocess Optimization

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 Market Overview |
1. 1.1 Study Assumptions & Market Definition |
2. 1.2 Scope of the Study |
3. 1.3 Research Methodology
2 Market Summary & Key Takeaways
3 Market Dynamics |
1. 3.1 Market Drivers Analysis | |
  1. 3.1.1 Cell and Gene Therapy Manufacturing Scale-Up | |
  2. 3.1.2 Government Biobank Expansion Programs | |
  3. 3.1.3 Elective Fertility Preservation Surge | |
  4. 3.1.4 GMP-Grade Media Regulatory Mandates | |
  5. 3.1.5 AI-Driven Bioprocess Optimization | |
  6. 3.1.6 Cord-Blood and Tissue Banking Reimbursement Reforms | |
  7. 3.1.7 Decentralized Clinical Trial Cold-Chain Logistics |
2. 3.2 Market Restraints Analysis | |
  1. 3.2.1 High Capital Cost of Automated Cryo-Storage Systems | |
  2. 3.2.2 DMSO Toxicity Concerns and Regulatory Scrutiny | |
  3. 3.2.3 Cold-Chain Logistics Gaps in Low-Income Regions | |
  4. 3.2.4 Lack of Harmonized International Biobanking Standards | |
  5. 3.2.5 Skilled Cryobiologist Workforce Shortages |
3. 3.3 Market Opportunity Analysis | |
  1. 3.3.1 Emerging-Market Biobank Build-Outs | |
  2. 3.3.2 Cryopreservation-as-a-Service Business Models | |
  3. 3.3.3 AI-Powered Bioprocess Optimization | |
  4. 3.3.4 DMSO-Free Cryoprotectant Development | |
  5. 3.3.5 Companion Diagnostics and Personalized Medicine Linkages |
4. 3.4 Industry Value Chain Analysis |
5. 3.5 Porter's Five Forces Analysis
4 Global Cell Cryopreservation Market Size & Forecast (2021–2035) |
1. 4.1 Historical Market Size (2021–2025) |
2. 4.2 Current & Forecast Market Size (2026–2035) |
3. 4.3 Market Size by Revenue (USD Billion) |
4. 4.4 Year-over-Year Growth Analysis
5 Segmentation Analysis |
1. 5.1 By Product | |
  1. 5.1.1 Cryopreservation Media | |
  2. 5.1.2 Equipment | |
  3. 5.1.3 Consumables |
2. 5.2 By Application | |
  1. 5.2.1 Stem Cells | |
  2. 5.2.2 Oocyte and Embryonic Cells | |
  3. 5.2.3 Sperm Cells | |
  4. 5.2.4 Hepatocytes | |
  5. 5.2.5 Other Cell Types |
3. 5.3 By End-User | |
  1. 5.3.1 Biopharmaceutical Companies | |
  2. 5.3.2 Research Institutes | |
  3. 5.3.3 Blood Banks | |
  4. 5.3.4 IVF Clinics
6 Regional Analysis |
1. 6.1 North America | |
  1. 6.1.1 United States | |
  2. 6.1.2 Canada | |
  3. 6.1.3 Mexico |
2. 6.2 Europe | |
  1. 6.2.1 Germany | |
  2. 6.2.2 United Kingdom | |
  3. 6.2.3 France | |
  4. 6.2.4 Italy | |
  5. 6.2.5 Spain | |
  6. 6.2.6 Nordic Countries | |
  7. 6.2.7 Russia | |
  8. 6.2.8 Rest of Europe |
3. 6.3 Asia-Pacific | |
  1. 6.3.1 China | |
  2. 6.3.2 India | |
  3. 6.3.3 Japan | |
  4. 6.3.4 South Korea | |
  5. 6.3.5 ASEAN | |
  6. 6.3.6 Rest of Asia-Pacific |
4. 6.4 South America | |
  1. 6.4.1 Brazil | |
  2. 6.4.2 Argentina | |
  3. 6.4.3 Rest of South America |
5. 6.5 Middle East & Africa | |
  1. 6.5.1 Saudi Arabia | |
  2. 6.5.2 UAE | |
  3. 6.5.3 South Africa | |
  4. 6.5.4 Egypt | |
  5. 6.5.5 Rest of MEA
7 Competitive Landscape |
1. 7.1 Market Share Analysis (2025) |
2. 7.2 Competitive Benchmarking Matrix |
3. 7.3 Company Profiles | |
  1. 7.3.1 Thermo Fisher Scientific | |
  2. 7.3.2 Merck KGaA | |
  3. 7.3.3 BioLife Solutions | |
  4. 7.3.4 Chart Industries | |
  5. 7.3.5 Exact Sciences | |
  6. 7.3.6 Worthington Industries | |
  7. 7.3.7 PHC Holdings (Panasonic HC) | |
  8. 7.3.8 Origen Biomedical | |
  9. 7.3.9 Azenta (Brooks Automation) | |
  10. 7.3.10 So-Low Environmental Equipment
8 Future Outlook & Strategic Recommendations (2026–2035) |
1. 8.1 AI and Autonomous Cryopreservation Operations |
2. 8.2 Industrialization of Cell Therapy Supply Chains |
3. 8.3 Sustainability in Cryogenic Operations |
4. 8.4 Harmonized Global Biobank Accreditation
9 Recent Developments & News
10 Frequently Asked Questions (FAQs)
11 Report Scope & Methodology |
1. 11.1 Study Period & Base Year |
2. 11.2 Data Sources & Citations |
3. 11.3 Abbreviations
12 LIST OF TABLES |
TABLE 1 Global Cell Cryopreservation Market Size & Forecast, by Revenue (USD Billion), 2021–2035 |
TABLE 2 Global Cell Cryopreservation Market — Year-over-Year Growth Analysis, 2021–2035 |
TABLE 3 Global Cell Cryopreservation Market — Driver Impact Analysis |
TABLE 4 Global Cell Cryopreservation Market — Restraint Impact Analysis |
TABLE 5 Global Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 6 Global Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 7 Global Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 8 Global Cell Cryopreservation Market Size, by Region, 2021–2035 (USD Billion) |
TABLE 9 North America Cell Cryopreservation Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 10 Europe Cell Cryopreservation Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 11 Asia-Pacific Cell Cryopreservation Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 12 South America Cell Cryopreservation Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 13 Middle East & Africa Cell Cryopreservation Market Size, by Country, 2021–2035 (USD Billion) |
TABLE 14 Competitive Benchmarking Matrix — Global Cell Cryopreservation Market, 2025 |
TABLE 15 Company Profiles — Key Players, Global Cell Cryopreservation Market |
TABLE 16 Recent Developments & Strategic Announcements, 2023–2025 |
TABLE 17 North America Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 18 North America Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 19 North America Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 20 Europe Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 21 Europe Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 22 Europe Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 23 Asia-Pacific Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 24 Asia-Pacific Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 25 Asia-Pacific Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 26 South America Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 27 South America Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 28 South America Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 29 Middle East & Africa Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 30 Middle East & Africa Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 31 Middle East & Africa Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 32 United States Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 33 United States Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 34 United States Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 35 Canada Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 36 Canada Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 37 Canada Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 38 Mexico Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 39 Mexico Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 40 Mexico Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 41 China Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 42 China Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 43 China Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 44 India Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 45 India Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 46 India Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 47 Japan Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 48 Japan Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 49 Japan Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 50 South Korea Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 51 South Korea Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 52 South Korea Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 53 Germany Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 54 Germany Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 55 Germany Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 56 United Kingdom Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 57 United Kingdom Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 58 United Kingdom Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 59 France Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 60 France Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 61 France Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 62 Brazil Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 63 Brazil Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 64 Brazil Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 65 Saudi Arabia Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 66 Saudi Arabia Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 67 Saudi Arabia Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 68 UAE Cell Cryopreservation Market Size, by Product, 2021–2035 (USD Billion) |
TABLE 69 UAE Cell Cryopreservation Market Size, by Application, 2021–2035 (USD Billion) |
TABLE 70 UAE Cell Cryopreservation Market Size, by End-User, 2021–2035 (USD Billion) |
TABLE 71 Report Scope & Methodology Summary |
TABLE 72 Detailed Sources and Citations
13 LIST OF FIGURES |
FIGURE 1 Cell Cryopreservation Market Dynamics — Drivers, Restraints, and Opportunities |
FIGURE 2 Cell Cryopreservation Market Value Chain Analysis |
FIGURE 3 Porter's Five Forces Analysis — Cell Cryopreservation Market |
FIGURE 4 Global Cell Cryopreservation Market Size Trend (USD Billion), 2021–2035 |
FIGURE 5 Cell Cryopreservation Market Share, by Product, 2025 (%) |
FIGURE 6 Cell Cryopreservation Market Share, by Application, 2025 (%) |
FIGURE 7 Cell Cryopreservation Market Share, by End-User, 2025 (%) |
FIGURE 8 Cell Cryopreservation Market Share, by Region, 2025 (%) |
FIGURE 9 North America Cell Cryopreservation Market Size Trend (USD Billion), 2021–2035 |
FIGURE 10 Europe Cell Cryopreservation Market Size Trend (USD Billion), 2021–2035 |
FIGURE 11 Asia-Pacific Cell Cryopreservation Market Size Trend (USD Billion), 2021–2035 |
FIGURE 12 South America Cell Cryopreservation Market Size Trend (USD Billion), 2021–2035 |
FIGURE 13 Middle East & Africa Cell Cryopreservation Market Size Trend (USD Billion), 2021–2035 |
FIGURE 14 Competitive Landscape — Market Share Distribution, 2025

Certified Researchers

Customize Report

Segmentation Quick Reference

Dimension	Sub-Segments	Dominant Segment	Fastest Growing Segment
By Product	Cryopreservation Media, Equipment, and Consumables	Cryopreservation Media	Equipment
By Application	Stem Cells, Oocyte and Embryonic Cells, Sperm Cells, Hepatocytes, Other Cell Types	Stem Cells	Oocyte and Embryonic Cells
By End-User	Biopharmaceutical Companies, Research Institutes, Blood Banks, IVF Clinics	Biopharmaceutical Companies	IVF Clinics
By Region	North America, Europe, Asia-Pacific, South America, Middle East & Africa	North America	Asia-Pacific

Market Segmentation Overview

By Product

Sub-Segment	Key Trend
Cryopreservation Media	Shift to GMP-grade, xeno-free, chemically defined formulations
Equipment	Automation of controlled-rate freezers with IoT monitoring
Consumables	Rising demand for single-use cryo-bags and vials in CGT manufacturing

Cryopreservation media continues to dominate product-level revenue as clinical-grade manufacturing mandates drive adoption of premium formulations. Equipment spending is accelerating as biobanks and biopharmaceutical facilities upgrade from manual dewars to automated, monitored storage platforms.

By Application

Sub-Segment	Key Trend
Stem Cells	Cord-blood and mesenchymal stem cell banking for CGT pipelines
Oocyte and Embryonic Cells	Vitrification adoption in elective and clinical fertility preservation
Sperm Cells	Expanding donor networks and direct-to-consumer sperm banking
Hepatocytes	Growing demand in ADME/tox testing and liver disease research
Other Cell Types	Immune-cell cryopreservation for CAR-T and organoid banking

Stem cells account for the largest application share, driven by commercial CGT manufacturing and expanding cord-blood repositories. Oocyte and embryonic cell preservation is the fastest-growing application as vitrification technology improves post-thaw outcomes and employer-sponsored fertility benefits broaden access.

By End-User

Sub-Segment	Key Trend
Biopharmaceutical Companies	Validated cryopreservation at multiple CGT supply-chain nodes
Research Institutes	Federally funded biobank capacity expansions
Blood Banks	Regulatory modernization of storage and tracking systems
IVF Clinics	Rapid growth in elective social egg and embryo freezing

Biopharmaceutical companies lead end-user spending as each CGT product commercialization creates recurring demand for preservation consumables and equipment. IVF clinics represent the fastest-growing channel, supported by global fertility treatment volume increases and supportive reimbursement trends.

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”